Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Ltd
Press Release Nov 23 2022
Business
Nov 23 2022
4 min read

Press Release Nov 23 2022

We enclose a copy of the Press Release issued by Acrotech Biopharma LLC, a step-down wholly owned subsidiary of the Company on entering into a license agreement with Evive Biotech to commercialize Ryzneuta��� Ryzneuta��� Ryzneuta��� Ryzneuta��� Ryzneuta��� Ryzneuta��� (Efbemalenograstim alfa) in the US in the US in the US in the US.

View Attachment